Brad Richardson
Analyst · Seaport Global. Your line is open
Well, thank you very much, Bob, and good morning. Let me first start with our GAAP results. We reported GAAP earnings per share from continuing operations of $0.30. Special items in the quarter resulted in a net after-tax charge of $10.5 million compared to $0.5 million in the prior year. The increase in special items is primarily related to the earnout adjustment associated with the Fiber-Line acquisition as the businesses’ performance has been exceptional, exceeding our original expectations. To reinforce Joe’s earlier comments, our results are presented on a continuing operations basis, which excludes the PP&S business, that is presented as a discontinued operation as a discontinued operation. Adjusted EPS for the quarter was $0.44, 7% higher than the prior year third quarter. This increase includes a headwind from a higher effective tax rate. At a constant tax rate, EPS would have been up 10%. Driving the growth in adjusted EPS was a 5% improvement in operating income, contributions from our Fiber-Line acquisitions, our growing composite portfolio and barrier additives continue to perform and differentiate us in what can be only characterized as a challenging economic environment. And as Bob said, we are benefiting from our earlier efforts to reduce cost and improve pricing and mix. From a regional perspective, organic sales in Europe were down 11%, primarily due to weak demand in automotive applications and unfavorable foreign currencies. Foreign currencies negatively impacted the region’s overall sales by 5%. Asia sales were down 7% as growth in the packaging end market from our barrier additive technologies was more than offset by weakness in the automotive and electronic end markets. Weaker foreign currencies impacted overall sales in the region by 2%. Still, despite the top line weakness in Asia, operating income grew 11% for the quarter due to improved mix from our wins in higher-margin specialty applications. As you know, the early days of our transformation are more known for mix improvement that drove margin expansion. But clearly, it’s still a focus of ours, as exemplified by the Asia results this quarter, and will continue to be. In reviewing our segments, SEM expanded revenue and operating income 10% and 7%, respectively. Strong performance from composites in North America wire and cable along with mix improvements were able to offset unfavorable FX and weakness in Europe and Asia. Driving the mix improvement for SEM were wins in health care applications where sale into this end market improved 19% in the third quarter and that follows a 25% growth in the second quarter this year. Examples of wins in applications that are driving the steady growth include a sensor delivery device for a continuous glucose monitor. The applicator inserts a small sensor just beneath the skin which continuously measures glucose level and sends the data wirelessly to a smartphone. The customer chose PolyOne because of our materials science expertise and medical-grade solutions and sophisticated formulations of FDA-compliant medical-grade polymers. PolyOne brought value to the OEM and its manufacturing network through both design and processing support to create consistency and accelerated product development. Another contributor to our recent SEM health care growth is the expansion of our NEU platform, which supplies formulations for catheter extrusions. These include specialty radiopaque and precolored materials as well as molded components used in intravenous and minimally invasive therapies. These are just a few examples of how we continue to innovate for our customers and improve our portfolio of specialty offering in less-cyclical end markets. Looking at our Color segment, revenue and operating income were down 6% and 7%, respectively. Weaker foreign currencies impacted both sales and operating income by 2%. From an end market perspective, growth in packaging and health care was more than offset by weakness in transportation applications and more recently, in North American consumer applications. The packaging end market continues to be a growth story within Color, as we have mentioned. Sales were up over 3% for the segment in the quarter, driven by continued market demand for our barrier additives. Asia led the way in this end market with 8% growth this quarter. And at the center stage was, once again, our Lactra SX additives serving the expanding drinkable yogurt market. Similar to SEM, health care sales were also up in Color growing 7% in the third quarter. Recent wins include a new application for a melatonin-related product, where we were able to provide a solution that not only met the desired aesthetic intent of product design but also provided the required UV protection for the pharma contents. Melatonin is UV-sensitive and easily degraded. Our solution met the technical requirements so well that our colorant was included in the patent filed by the OEM for this application. Another example including winning a personal care product application for an existing customer, who is launching a private-label branded product for one of its customers, a prominent global retailer. Because of our long-standing expertise in this market and ability to provide consistent solutions used in this particular medical Class 1 application, we earned the business. And yet another example included a great collaboration effort between our Color and Distribution teams. Our Distribution team received the lead and we ultimately won the business over the competitor for a health care housing application. We were selected by this customer based on their speed-to-market requirements for a custom color design and the OEM’s desire for a single point of contact. Our supplier relationships in Distribution enabled us to obtain the resin quickly to then expedite the color design and sample to the customer. With an on-target sample, the application was approved and immediately followed by commercial orders. Fast response and an accurate design enabled the win for PolyOne. It’s also a great example of the strategic fit of our Distribution business and how we can leverage the customer and supplier relationship to grow all of our businesses. And speaking of Distribution, it had yet another quarter of operating income growth. The segment grew operating income 7% on operating margin expansion from improved mix and pricing. The mix improvement was primarily related to gains in the outdoor high performance, which now makes up approximately 8% of POD’s segment revenues. In the third quarter, volume was up 18% in this growing end market through a combination of new wins and expanding with existing large customers, particularly in the recreation and ATV applications. I’d also like to add what Bob said about POV’s presence in health care. In 2013 about 20% of segment revenues were health care. Today, it’s nearly 30%. Health care is a growing point of differentiation for our Distribution business and is contributing to our company’s ongoing movement towards higher-margin, less-cyclical end markets, regardless of the segment. Before I turn the call back over to Bob, I wanted to highlight the recent 4% increase in our dividend, marking the ninth consecutive year of increases. The latest increase reflects our track record of growing earnings over the long term and our confidence to continue doing so in the future. This [Audio Gap] the same ways that we have in the past to benefit all of our many stakeholders. That is investing in innovation and acquiring specialty companies to deliver differentiated performance, and rewarding our shareholders through earnings growth, our quarterly dividend and opportunistic share repurchases. With that, I’ll turn the call back over to Bob.